Curis
CRIS
#11076
Rank
C$5.82 M
Marketcap
C$0.61
Share price
-9.03%
Change (1 day)
-62.89%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -C$12.48 Million

According to Curis's latest financial reports the company's current earnings are C$4.31 Million. In 2025 the company made an earning of -C$7.74 Million, an increase over its 2024 earnings that were of -C$61.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$12.48 Million61.19%
2025 -C$7.74 Million-87.38%
2024 -C$61.34 Million-5.77%
2023 -C$65.1 Million-13.1%
2022 -C$74.91 Million27.52%
2021 -C$58.75 Million65.09%
2020 -C$35.59 Million-9.1%
2019 -C$39.15 Million-4.73%
2018 -C$41.09 Million-41.95%
2017 -C$70.77 Million-14.37%
2016 -C$82.65 Million3.55%
2015 -C$79.81 Million271.52%
2014 -C$21.49 Million76.64%
2013 -C$12.17 Million
2011 -C$10.33 Million27.76%
2010 -C$8.09 Million-43.87%
2009 -C$14.41 Million-23.44%
2008 -C$18.82 Million56.66%
2007 -C$12.01 Million-16.71%
2006 -C$14.42 Million-36.92%
2005 -C$22.86 Million156.25%
2004 -C$8.92 Million-37.24%
2003 -C$14.22 Million-93.34%
2002 -C$0.22 Billion86.79%
2001 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.99 B-82,581.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.25 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-C$88.74 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.52 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.47 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-C$31.93 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-C$0.28 Billion 2,203.50%๐Ÿ‡บ๐Ÿ‡ธ USA